MACH7 TECHNOLOGIES LIMITED — Director's Dealing 2021

May 2, 2021

==> picture [104 x 26] intentionally omitted <==

ASX Announcement

Change of Director’s Interest Notice

Melbourne, Australia; 3 May 2021: Mach7 Technologies Limited (ASX:M7T), a company specialising in innovative data management solutions for healthcare providers, provides Appendix 3Y - Change of Director’s Interests Notice for CEO & Managing Director, Mike Lampron.

Mike Lampron has recently exercised 116,667 options and sold 116,607 of the resulting shares on-market. The reason for the transaction is to enable Mike to meet a US tax obligation by May 15, 2021.

This announcement has been approved for lodgment by the Company Secretary.

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative data management solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their bestof-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit Mach7t.com.

For more information, contact:

Jenni Pilcher CFO, Mach7 jenni.pilcher@mach7t.com

Andrew Keys Registered Office: Investor Relations Level 2, 20 Collins Street andrew.keys@keysthomas.com Melbourne, 3000

==> picture [180 x 63] intentionally omitted <==

==> picture [74 x 9] intentionally omitted <==

Mach7 Technologies Limited ABN 26 007 817 192 ASX:M7T

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Mach7 Technologies Limited ABN 26 007 817 192

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mike Lampron
Date of last notice	2 December 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	26 & 30 April 2021
No. of securities held prior to change	1,450,000 unlisted options 85,148 fully paid ordinary shares 378,114 Performance Rights
Class	Unlisted Options Fully Paid Ordinary Shares
Number acquired	116,667 Fully Paid Ordinary Shares
Number disposed	116,607 Fully Paid Ordinary Shares Sold 116,667 Unlisted Options Exercised
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.175 per Share acquired upon exercise of options $1.207 per Share disposed
No. of securities held after change	1,333,333 unlisted options 85,208 fully paid ordinary shares 378,114 Performance Rights

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Exercise of options, and on-market trade Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011